Article
Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.
Journal of autism and developmental disorders - 1 Jun 2005
Sugie Yoko, Sugie Hideo, Fukuda Tokiko, Ito Masataka, Sasada Yumiko, Nakabayashi Mutsumi, Fukashiro Kazunobu, Ohzeki Takehiko
Abstract excerpt
We studied the correlation between response to fluvoxamine and serotonin transporter gene promoter region polymorphism (5-HTTLPR). Eighteen children with autistic disorder completed a 12-week double-blind, placebo-controlled, randomized crossover study of fluvoxamine. Behavioral assessments were obtained before and at 12 weeks of treatment. 5-HTTLPR (long (l) or short(s)), was analyzed by the PCR method. Ten out...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
